Optimizing Treatment of Complex Bifurcation Lesions

Optimizing Treatment of Complex Bifurcation Lesions

On-Demand Webcast

D. Chris Metzger, MD, FACC, FSCAI
Director of Cardiac and Peripheral Vascular Cath Labs
Medical Director of Clinical Research
Wellmont CVA Heart Institute
Kingsport, Tennessee

Ziad A. Ali, MD, DPhil
Assistant Professor of Medicine
Associate Director of Translational Medicine
Victoria and Esther Aboodi Cardiology Researcher
Louis V Gerstner Scholar
Columbia University
Director Angiographic Core Laboratory
Cardiovascular Research Foundation
New York, New York

Intended Learners

This activity is designed for interventional cardiologists, vascular surgeons, interventional radiologists, cardiothoracic surgeons, clinical cardiologists, nurses, technicians and others involved in the treatment of complex coronary lesions. 

Learning Objectives

After completing this activity, participants should be able to

  • Identify options and risks associated with the treatment of a bifurcation lesion. 
  • Identify lesions of the side branch and the best possible treatment approach based on vessel size.
  • Compare and contrast emerging technologies used to treat complex bifurcations.
Activity Overview

In order to be eligible for documentation of credit, participants must complete the pre-test, attend the full webinar, complete the 10-question post-test with a score of 75% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit. Participants will be asked to complete a pre-activity survey, post-activity survey and evaluation following the educational session. Participants will be asked to log in or create an account at www.naccme.com.

For questions regarding this educational activity, please call 609-371-1137.

There is no fee associated with this activity.

Release Date: December 15, 2017
Expiration Date: December 15, 2019
Estimated Time to Complete: 1 hour

Hardware/Software Requirements

The evaluation is accessible after the activity via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.


In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This continuing nursing education activity awards 1 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1 contact hour.

Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.

ARRT Credit

Optimizing Treatment of Bifurcation Lesions has been approved for 1 ARRT Category A CE credit by The Association for Medical Imaging Management, AHRA. 

AHRA is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).

Device Name Disclosure

This continuing medical education activity may include device brand names for participant clarity purposes only, due to the presence of different branded versions of the same device. No product promotion or recommendation should be inferred.


Brand Name Disclosure

This continuing medical education activity may include medication brand names for participant clarity purposes only, due to the presence of different branded versions of the same agent. No product promotion or recommendation should be inferred. 

Planning Committee

The planning committee comprises D. Chris Metzger, MD, FACC, FSCAI, Ziad A. Ali, MD, DPhil, Robert S. Dieter, MD, RVT, FACC, Susie Seaman, NP, and MaryEllen Fama, Emily Gibson, Jennifer Ilcyn, Todd Kunkler, Randy Robbin, John Savage, Stephanie Weiss, and Colleen Waters, NACCME.

Independent Clinical Reviewer: Robert S. Dieter, MD, RVT, FACC, Loyola University Medicine, Chicago, Illinois

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Ali: Consultant -St Jude Medical, Abbott Vascular, Cardiovascular Systems Inc., Boston Scientific, Cordis, Medtronic

Dr. Metzger: Consultant - Abbott Vascular; Speaker's Bureau - Boston Scientific; Speakers Bureau - CSI, Imaging & Innovation

Ms. Seaman: Advisory Board—Mölnlycke

Dr. Dieter, Ms. Fama, Ms. Gibson, Ms. Ilcyn, Mr. Kearney, Mr. Robbin, Mr. Savage, and Ms. Weiss have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed that no off-label/unapproved uses of drugs and/or devises will be discussed in the presentations.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2017 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

Supported by an educational grant from Cordis, A Cardinal Health Company.